Should we still be concerned about the potential side effects of glucagon-like peptide-1 receptor agonists on thyroid C cells?
Crossref DOI link: https://doi.org/10.1007/s12020-014-0354-3
Published Online: 2014-07-18
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Cao, Yang
Liu, Xiao-Min
Text and Data Mining valid from 2014-07-18
